This country profile provides an overview of Senegal’s progress in reaching those in need of mass NTD treatment based on 2017 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Download country profiles
Treatment coverage
Elephantiasis
71% Blinding trachoma
70% Intestinal worms
57% Bilharzia
91% River blindness
48% 7.52 million people received treatment in Senegal in 2017 4.49 million people did not receive treatment in Senegal in 2017
Priorities for progress in Senegal
- Senegal should continue to build the preventive chemotherapy programme for all of the five diseases, with systematic annual high-coverage implementation of all components, in all risk groups, as recommended by WHO.
- Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.
Elephantiasis
Treatment maintained its coverage of 71% from 2016 to 2017.
People needing treatment
8.81m People receiving treatment
6.23m Blinding trachoma
Treatment coverage increased from 15% in 2016 to 70% in 2017.
People needing treatment
1.52m People receiving treatment
1.06m Intestinal worms
Treatment coverage decreased from 63% in 2016 to 57% in 2017.
Pre-sch and school-aged children needing treatment
6.62m Pre-school and school-aged children receiving treatment
3.79m Bilharzia
Treatment coverage increased from 35% in 2016 to 91% in 2017.
School-aged children needing treatment
1.68m School-aged children receiving treatment
1.53m River blindness
Treatment coverage decreased from 69% in 2016 to 48% in 2017.
People needing treatment
0.71m People receiving treatment
0.35m The 
ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Senegal.